Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neuroradiology

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00234-011-0874-yPMID 21541688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measuring the integrity of the human blood-brain barrier using magnetic resonance imaging.

  2011cited by this paper
• Comparative Evaluation of Dynamic Contrast-Enhanced Perfusion With Diffusion Tensor Imaging Metrics in Assessment of Corticospinal Tract Infiltration in Malignant Glioma

  2010cited by this paper
• An extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9.

  2010cited by this paper
• Quantitative permeability magnetic resonance imaging in acute ischemic stroke: how long do we need to scan?

  2009cited by this paper
• Dynamic Contrast-Enhanced Derived Cerebral Blood Volume Correlates Better With Leak Correction Than With No Correction for Vascular Endothelial Growth Factor, Microvascular Density, and Grading of Astrocytoma

  2008cited by this paper
• Serial diffusion tensor imaging to characterize radiation-induced changes in normal-appearing white matter following radiotherapy in patients with adult low-grade gliomas

  2008cited by this paper
• Translational Control of C-terminal Src Kinase (Csk) Expression by PRL3 Phosphatase*

  2008cited by this paper
• Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI

  2008cited by this paper
• The value and correlation between PRL‐3 expression and matrix metalloproteinase activity and expression in human gliomas

  2007cited by this paper
• Evidence for differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature.

  2007cited by this paper
• Quantification of physiological and hemodynamic indices using T1 dynamic contrast‐enhanced MRI in intracranial mass lesions

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.

  2007cited by this paper
• Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.

  2006cited by this paper
• Metalloproteinases: Mediators of Pathology and Regeneration in the CNS

  2005cited by this paper
• Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells.

  2004cited by this paper
• Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells.

  2004cited by this paper
• Alterations in Vascular Gene Expression in Invasive Breast Carcinoma

  2004cited by this paper
• Proteases in brain tumour progression

  2003cited by this paper
• Molecular mechanisms of glioma invasiveness: the role of proteases

  2003cited by this paper
• Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.

  2002cited by this paper
• A Phosphatase Associated with Metastasis of Colorectal Cancer

  2001cited by this paper
• The Role of Matrix Metalloproteinase Genes in Glioma Invasion: Co-dependent and Interactive Proteolysis

  2001cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• MR perfusion imaging of the brain: techniques and applications.

  2000cited by this paper
• VEGFs, receptors and angiogenesis.

  1999cited by this paper
• Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas

  1999cited by this paper
• Stabilization of wild-type p53 by hypoxia-inducible factor 1α

  1998cited by this paper
• p53 Inhibits Hypoxia-inducible Factor-stimulated Transcription*

  1998cited by this paper
• The biology of vascular endothelial growth factor.

  1997cited by this paper
• Isolation of Putative Progenitor Endothelial Cells for Angiogenesis

  1997cited by this paper
• Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.

  1994cited by this paper
• Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma.

  1993cited by this paper
• Grading of astrocytomas: A simple and reproducible method

  1988cited by this paper

• Role of dynamic contrast-enhanced and dynamic susceptibility contrast imaging in evaluating the biological features of glioma

  2025cites this paper
• Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma

  2024cites this paper
• Review of tracer kinetic models in evaluation of gliomas using dynamic contrast-enhanced imaging

  2024cites this paper
• Glioma grading using an optimized T1-weighted dynamic contrast-enhanced magnetic resonance imaging paradigm

  2024cites this paper
• Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype

  2023cites this paper
• Whole-tumor histogram analysis of diffusion-weighted imaging and dynamic contrast-enhanced MRI for soft tissue sarcoma: correlation with HIF-1alpha expression

  2022cites this paper
• Assessing Tumour Haemodynamic Heterogeneity and Response to Choline Kinase Inhibition Using Clustered Dynamic Contrast Enhanced MRI Parameters in Rodent Models of Glioblastoma

  2022cites this paper
• Hemodynamic Imaging in Cerebral Diffuse Glioma—Part B: Molecular Correlates, Treatment Effect Monitoring, Prognosis, and Future Directions

  2022cites this paper
• Hemodynamic Imaging in Cerebral Diffuse Glioma—Part A: Concept, Differential Diagnosis and Tumor Grading

  2022cites this paper
• Soft tissue sarcoma: correlation of dynamic contrast-enhanced magnetic resonance imaging features with HIF-1α expression and patient outcomes

  2022cites this paper
• Repeatability of tumor perfusion kinetics from dynamic contrast-enhanced MRI in glioblastoma

  2021cites this paper
• DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients.

  2021cites this paper
• DCE-MRI in Glioma, Infiltration Zone and Healthy Brain to Assess Angiogenesis: A Biopsy Study

  2021cites this paper
• Non-Invasive Estimation of Glioma IDH1 Mutation and VEGF Expression by Histogram Analysis of Dynamic Contrast-Enhanced MRI

  2020cites this paper
• VEGF levels in patients with glioma: a systematic review and meta-analysis

  2020cites this paper
• The diagnostic value of quantitative analysis of ASL, DSC-MRI and DKI in the grading of cerebral gliomas: a meta-analysis

  2020cites this paper
• Simplified Perfusion Fraction from Diffusion-weighted Imaging in Preoperative Prediction of IDH1 Mutation in WHO Grade II–III Gliomas: Comparison with Dynamic Contrast-enhanced and Intravoxel Incoherent Motion MRI

  2020cites this paper
• Radiogenomic analysis of vascular endothelial growth factor in patients with diffuse gliomas

  2019cites this paper
• MRI Perfusion Measurements using Magnetic Susceptibility Effects: : Calibration Approaches and Contrast Agent Quantification

  2019cites this paper
• Inter-observer reproducibility of quantitative dynamic susceptibility contrast and diffusion MRI parameters in histogram analysis of gliomas

  2019cites this paper
• Can dynamic contrast-enhanced MRI evaluate VEGF expression in brain glioma? An MRI-guided stereotactic biopsy study.

  2019cites this paper
• Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression

  2019cites this paper
• DCE-MRI in Human Gliomas: A Surrogate for Assessment of Invasive Hypoxia Marker HIF-1Α Based on MRI-Neuronavigation Stereotactic Biopsies.

  2019cites this paper
• Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI.

  2019cites this paper
• Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best?

  2019cites this paper
• Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best?

  2019cites this paper
• Characterization of breast lesion using T1-perfusion magnetic resonance imaging: Qualitative vs. quantitative analysis.

  2018cites this paper
• The antitumour growth and antiangiogenesis effects of xanthatin in murine glioma dynamically evaluated by dynamic contrast‐enhanced magnetic resonance imaging

  2018cites this paper
• Assessment of the Agreement between Cerebral Hemodynamic Indices Quantified Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced Perfusion Magnetic Resonance Imagings

  2018cites this paper
• Correlations among Apparent Diffusion Coefficient and Permeability Parameters from Dynamic Contrast-enhanced MR in Brain Tumor Parenchyma and Peritumoral Area

  2018cites this paper
• Early Changes in Tumor Perfusion from T1-Weighted Dynamic Contrast-Enhanced MRI following Neural Stem Cell-Mediated Therapy of Recurrent High-Grade Glioma Correlate with Overall Survival

  2018cites this paper
• Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.

  2018cites this paper
• Dynamic Contrast Enhanced MRI in Glioma Diagnosis

  2017cites this paper
• Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis.

  2017cites this paper
• Noninvasively detecting Isocitrate dehydrogenase 1 gene status in astrocytoma by dynamic susceptibility contrast MRI

  2017cites this paper
• Prognostic aspects of dynamic contrast-enhanced magnetic resonance imaging in synchronous distant metastatic rectal cancer

  2017cites this paper
• The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma

  2017cites this paper
• Differential diagnosis of posterior fossa brain tumors

  2017cites this paper
• Evaluation of B1 inhomogeneity effect on DCE-MRI data analysis of brain tumor patients at 3T

  2017cites this paper
• Perfusion kinetics in human brain tumor with DCE-MRI derived model and CFD analysis.

  2017cites this paper
• Diagnostic accuracy of automatic normalization of CBV in glioma grading using T1- weighted DCE-MRI.

  2017cites this paper
• Transport of Liposome Encapsulated Drugs in Voxelized Computational Model of Human Brain Tumors

  2017cites this paper
• Use Case II: Imaging Biomarkers and New Trends for Integrated Glioblastoma Management

  2017cites this paper
• Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.

  2017cites this paper
• Erratum to: Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics

  2016cites this paper
• Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients

  2016cites this paper
• Artificial Neural Networks approach to pharmacokinetic model selection in DCE-MRI studies.

  2016cites this paper
• Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics

  2016cites this paper
• Strategies to target drugs to gliomas and CNS metastases of solid tumors

  2016cites this paper
• Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.

  2016cites this paper
• Dynamic Contrast‐Enhanced MRI in Low‐Grade Versus Anaplastic Oligodendrogliomas

  2016cites this paper
• Comparison of actual with default hematocrit value in dynamic contrast enhanced MR perfusion quantification in grading of human glioma.

  2016cites this paper
• Human Papillomavirus and Epidermal Growth Factor Receptor in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma: Correlation With Dynamic Contrast-Enhanced MRI Parameters.

  2016cites this paper
• Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced MR in Tumor Parenchyma and Peritumoral Area for Distinction of Brain Tumors

  2015cites this paper
• [Multiparametric imaging with simultaneous MRI/PET: Methodological aspects and possible clinical applications].

  2015cites this paper
• Diagnosis of brain tumors using dynamic contrast-enhanced perfusion imaging with a short acquisition time

  2015influential citation
• Multiparametrische Bildgebung mittels simultaner MR/PET Methodische Aspekte und klinische Anwendungsmöglichkeiten

  2015cites this paper
• Optimization of the reference region method for dual pharmacokinetic modeling using Gd‐DTPA/MRI and 18F‐FDG/PET

  2015cites this paper
• Predictors of Survival in Patients with Glioblastomas

  2015cites this paper
• Multiparametrische Bildgebung mittels simultaner MR/PET

  2015cites this paper
• Intraoperative Magnetic Resonance Imaging in Neurosurgery: Part I—A Review of History, Use, and Outcomes

  2014cites this paper
• Glioma: Application of Histogram Analysis of Pharmacokinetic Parameters from T1-Weighted Dynamic Contrast-Enhanced MR Imaging to Tumor Grading

  2014cites this paper
• MR Perfusion Imaging: ASL, T2*-Weighted DSC, and T1-Weighted DCE Methods

  2014cites this paper
• Functional Magnetic Resonance Techniques in CNS Tumors

  2014cites this paper
• Intraoperative Magnetic Resonance Imaging in Neurosurgery: Part II—Brain Shift, Perioperative Complications, and Costs

  2014cites this paper
• Perfusion Imaging and Hyperpolarized Agents for MRI

  2014cites this paper
• Classification/Diagnosis of Brain Tumors Using Discriminant Function Analysis

  2014cites this paper
• T2*‐correction in dynamic contrast‐enhanced MRI from double‐echo acquisitions

  2014cites this paper
• Using intraoperative dynamic contrast-enhanced T1-weighted MRI to identify residual tumor in glioblastoma surgery.

  2014cites this paper
• A review of technical aspects of T1-weighted dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in human brain tumors.

  2014cites this paper
• Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome.

  2014cites this paper
• Value of Perfusion Weighted Magnetic Resonance Imaging in the Diagnosis of Supratentorial Anaplastic Astrocytoma

  2014cites this paper
• Advanced magnetic resonance imaging of the physical processes in human glioblastoma.

  2014cites this paper
• Utility of multiparametric 3-T MRI for glioma characterization

  2013influential citation
• [Multiparametric imaging with simultaneous MR/PET. Methodological aspects and possible clinical applications].

  2013cites this paper
• Multivariate discriminant analysis of multiparametric brain MRI to differentiate high grade and low grade gliomas — A computer-aided diagnosis development study

  2013cites this paper
• Comparative Evaluation of 3-Dimensional Pseudocontinuous Arterial Spin Labeling With Dynamic Contrast-Enhanced Perfusion Magnetic Resonance Imaging in Grading of Human Glioma

  2013cites this paper
• Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high‐ and low‐grade glioma using dynamic contrast‐enhanced (DCE) MRI

  2013cites this paper
• Glioma Grading Capability: Comparisons among Parameters from Dynamic Contrast-Enhanced MRI and ADC Value on DWI

  2013cites this paper
• Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.

  2013cites this paper
• T1-Weighted Dynamic Contrast-Enhanced MR Evaluation of Different Stages of Neurocysticercosis and Its Relationship with Serum MMP-9 Expression

  2013cites this paper
• Conversion of arterial input functions for dual pharmacokinetic modeling using Gd‐DTPA/MRI and 18F‐FDG/PET

  2013cites this paper
• New similarity search based glioma grading

  2012cites this paper
• Using contrast agents to obtain maps of regional perfusion and capillary wall permeability

  2012cites this paper
• solid Pancreatic lesions : Characterization by Using Timing Bolus Dynamic Contrast-enhanced MR Imaging Assessment — A Preliminary Study 1

  2012cites this paper
• Clinical manifestations and diagnostic imaging of brain tumors.

  2012cites this paper